1999
DOI: 10.1007/978-1-4615-4859-1_8
|View full text |Cite
|
Sign up to set email alerts
|

Animal Models of Menkes Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

1999
1999
2018
2018

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(8 citation statements)
references
References 33 publications
0
8
0
Order By: Relevance
“…6 A mouse model called the mottled mouse has also been shown to have mutations in the mouse homolog of ATP7A with different mutations causing a variety of neurologic manifestations and degeneration of neurons. 10 Copper deficiency induced in rats by the copper chelater iminodiproprionitrile causes aberrant behavior, including abnormal movements and gait difficulties, and also causes vacuolization of the ventral horn. 4 Lastly, mutations in copper/zinc superoxide dismutase cause familial ALS and, although the exact mechanism of this disease is not known, improper metal binding has been proposed as a mechanism by which mutations cause their toxic gain of function.…”
Section: Discussionmentioning
confidence: 99%
“…6 A mouse model called the mottled mouse has also been shown to have mutations in the mouse homolog of ATP7A with different mutations causing a variety of neurologic manifestations and degeneration of neurons. 10 Copper deficiency induced in rats by the copper chelater iminodiproprionitrile causes aberrant behavior, including abnormal movements and gait difficulties, and also causes vacuolization of the ventral horn. 4 Lastly, mutations in copper/zinc superoxide dismutase cause familial ALS and, although the exact mechanism of this disease is not known, improper metal binding has been proposed as a mechanism by which mutations cause their toxic gain of function.…”
Section: Discussionmentioning
confidence: 99%
“…We investigated two independently derived genetic models of copper overload containing mutations in the same gene to discriminate between cell-specific effects and the effects of copper. Both of these mutations result in severe loss of function in the Atp7a gene (33). Both mutants result in a cellular defect in copper efflux that leads to similar levels of intracellular copper accumulation in cultured cells.…”
Section: Discussionmentioning
confidence: 99%
“…Excess copper is normally exported by the ATP7A copper transporting P-type ATPase, which translocates from the trans-Golgi network (TGN) to the plasma membrane in the presence of elevated copper (45). Mutations in ATP7A in both humans (Menkes disease) and mice (mottled mouse) lead to reduced intestinal basolateral export of copper and subsequent systemic copper deficiency (33). All cultured cells tested, with the exception of hepatic cells, from mottled mice accumulate copper to abnormally high levels in normal culture media (12,32).…”
mentioning
confidence: 99%
“…The high affinity copper uptake protein Ctr1 is responsible for making copper that enters via the apical membrane available in the cytosol for further utilization (1), whereas the copper-transporting ATPase ATP7A facilitates copper exit from the enterocytes into circulation (2) (Figure 1). Complete genetic inactivation of either transporter in experimental animals is embryonically lethal (3)(4)(5). However, partial inactivation or tissue specific inactivation of ATP7A or Ctr1, respectively, in either case is associated with copper accumulation in the intestine, impaired copper entry into the bloodstream, and severe copper deficiency in many organs and tissues (1).…”
Section: Copper Homeostasis In Mammalsmentioning
confidence: 99%